Division of Critical Care Medicine, Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America.
Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, United States of America.
PLoS Pathog. 2024 Jul 11;20(7):e1012394. doi: 10.1371/journal.ppat.1012394. eCollection 2024 Jul.
Staphylococcus aureus is a facultative intracellular pathogen of human macrophages, which facilitates chronic infection. The genotypes, pathways, and mutations influencing that phenotype remain incompletely explored. Here, we used two distinct strategies to ascertain S. aureus gene mutations affecting pathogenesis in macrophages. First, we analyzed isolates collected serially from chronic cystic fibrosis (CF) respiratory infections. We found that S. aureus strains evolved greater macrophage invasion capacity during chronic human infection. Bacterial genome-wide association studies (GWAS) identified 127 candidate genes for which mutation was significantly associated with macrophage pathogenesis in vivo. In parallel, we passaged laboratory S. aureus strains in vitro to select for increased infection of human THP-1 derived macrophages, which identified 15 candidate genes by whole-genome sequencing. Functional validation of candidate genes using isogenic transposon mutant knockouts and CRISPR interference (CRISPRi) knockdowns confirmed virulence contributions from 37 of 39 tested genes (95%) implicated by in vivo studies and 7 of 10 genes (70%) ascertained from in vitro selection, with one gene in common to the two strategies. Validated genes included 17 known virulence factors (39%) and 27 newly identified by our study (61%), some encoding functions not previously associated with macrophage pathogenesis. Most genes (80%) positively impacted macrophage invasion when disrupted, consistent with the phenotype readily arising from loss-of-function mutations in vivo. This work reveals genes and mechanisms that contribute to S. aureus infection of macrophages, highlights differences in mutations underlying convergent phenotypes arising from in vivo and in vitro systems, and supports the relevance of S. aureus macrophage pathogenesis during chronic respiratory infection in CF. Additional studies will be needed to illuminate the exact mechanisms by which implicated mutations affect their phenotypes.
金黄色葡萄球菌是人类巨噬细胞的兼性胞内病原体,可导致慢性感染。影响这种表型的基因型、途径和突变仍未被充分探索。在这里,我们使用两种不同的策略来确定影响巨噬细胞发病机制的金黄色葡萄球菌基因突变。首先,我们分析了从慢性囊性纤维化(CF)呼吸道感染中连续采集的分离株。我们发现,金黄色葡萄球菌菌株在慢性人类感染过程中进化出更强的巨噬细胞入侵能力。细菌全基因组关联研究(GWAS)确定了 127 个候选基因,这些基因的突变与体内巨噬细胞发病机制显著相关。同时,我们在体外传代实验室金黄色葡萄球菌菌株以选择增加对人 THP-1 衍生巨噬细胞的感染,通过全基因组测序确定了 15 个候选基因。使用同源转座子突变敲除和 CRISPR 干扰(CRISPRi)敲低对候选基因的功能验证,确认了 39 个经体内研究和 7 个经体外选择鉴定的候选基因(分别为 95%和 70%)的毒力贡献,其中一个基因两种策略共有。验证的基因包括 17 个已知的毒力因子(39%)和 27 个我们研究新发现的(61%),其中一些基因编码的功能以前与巨噬细胞发病机制无关。大多数基因(80%)在功能中断时都能显著影响巨噬细胞的入侵,这与体内易于出现功能丧失突变的表型一致。这项工作揭示了导致金黄色葡萄球菌感染巨噬细胞的基因和机制,突出了来自体内和体外系统的趋同表型的突变差异,并支持金黄色葡萄球菌在 CF 慢性呼吸道感染期间的巨噬细胞发病机制的相关性。还需要进一步的研究来阐明所涉及的突变影响其表型的确切机制。